￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
028-123456789
Menu

Medical News

Interpretation of the 2021 medical insurance policy for Gitairinib (afatinib) Please take 2 minutes to read it

2025-10-19 11:44:20

Check Details
Deciphering the drug properties of Iressa (gefitinib) and who is suitable for using this targeted drug_ Kanghule

2025-10-19 11:44:20

Check Details
What is the effective target of gefitinib? People targeted by lung cancer want to know about the speed points

2025-10-19 11:44:20

Check Details
Do I need to be tested before taking the targeted drug cabozantinib?

2025-10-19 11:44:20

Check Details
【Are you curious】What will happen to your skin after using Gitairinib (afatinib)

2025-10-19 11:44:20

Check Details
up to date! Xakori (Crizotinib) medical insurance reimbursement requirements. If you want to be reimbursed, please click here

2025-10-19 11:44:20

Check Details
How effective is gefitinib in the treatment of locally advanced or metastatic non-small cell lung cancer? See what the experts say

2025-10-19 11:44:20

Check Details
The latest medical insurance reimbursement conditions for the lung cancer targeted drug gefitinib are here, and lung cancer patients are overjoyed

2025-10-19 11:44:20

Check Details
How long does it take to develop drug resistance after taking Giterinib (afatinib)? Expert advice

2025-10-19 11:44:20

Check Details
Data on the efficacy of the targeted drug cabozantinib in the treatment of RET rearranged lung cancer

2025-10-19 11:44:20

Check Details
Increase the reimbursement ratio? The latest interpretation of Jitai Rui’s 2021 medical insurance reimbursement policy

2025-10-19 11:44:20

Check Details
Can Xekori (crizotinib capsules) be reimbursed by medical insurance? What is the latest reimbursement rate?

2025-10-19 11:44:20

Check Details
Category
相关知识